Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Mark Alex Varvares, M.D.

Concepts

This page shows the publications Mark Varvares has written about Head and Neck Neoplasms.
Connection Strength

7.339
  1. Trends in the Implementation of Multidisciplinary Care in Patients With Head and Neck Cancer. JAMA Otolaryngol Head Neck Surg. 2020 12 01; 146(12):1146-1148.
    View in: PubMed
    Score: 0.345
  2. State Medicaid expansion status, insurance coverage and stage at diagnosis in head and neck cancer patients. Oral Oncol. 2020 11; 110:104870.
    View in: PubMed
    Score: 0.335
  3. Understanding approaches to measurement and impact of depth of invasion of oral cavity cancers: A survey of American Head and Neck Society Membership. Oral Oncol. 2019 12; 99:104461.
    View in: PubMed
    Score: 0.320
  4. Preoperative anemia displays a dose-dependent effect on complications in head and neck oncologic surgery. Head Neck. 2019 09; 41(9):3033-3040.
    View in: PubMed
    Score: 0.309
  5. What's Love Got to do with it? Marital status and survival of head and neck cancer. Eur J Cancer Care (Engl). 2019 Jul; 28(4):e13022.
    View in: PubMed
    Score: 0.305
  6. Assessing functional outcomes in head and neck surgical oncology. Head Neck. 2019 07; 41(7):2051-2057.
    View in: PubMed
    Score: 0.304
  7. Opioid Prescription Patterns Among Patients With Head and Neck Cancer. JAMA Otolaryngol Head Neck Surg. 2018 Apr 01; 144(4):382-383.
    View in: PubMed
    Score: 0.287
  8. Preoperative laboratory data are associated with complications and surgical site infection in composite head and neck surgical resections. Am J Otolaryngol. 2018 May - Jun; 39(3):261-265.
    View in: PubMed
    Score: 0.283
  9. Decreased cancer-independent life expectancy in the head and neck cancer population. Head Neck. 2017 09; 39(9):1845-1853.
    View in: PubMed
    Score: 0.272
  10. Frailty index: Intensive care unit complications in head and neck oncologic regional and free flap reconstruction. Head Neck. 2017 08; 39(8):1578-1585.
    View in: PubMed
    Score: 0.269
  11. Impact of treatment modality on quality of life of head and neck cancer patients: Findings from an academic medical institution. Am J Otolaryngol. 2017 Mar - Apr; 38(2):168-173.
    View in: PubMed
    Score: 0.263
  12. Competing causes of death in the head and neck cancer population. Oral Oncol. 2017 02; 65:8-15.
    View in: PubMed
    Score: 0.262
  13. Oncologic Outcomes of Invasive Squamous Cell Carcinoma of the Scalp Requiring Resection of Cranial Bone. J Neurol Surg A Cent Eur Neurosurg. 2016 Jul; 77(4):308-11.
    View in: PubMed
    Score: 0.246
  14. Suicide: A Major Threat to Head and Neck Cancer Survivorship. J Clin Oncol. 2016 Apr 01; 34(10):1151.
    View in: PubMed
    Score: 0.246
  15. Predictors of stage at presentation and outcomes of head and neck cancers in a university hospital setting. Head Neck. 2016 04; 38 Suppl 1:E1826-32.
    View in: PubMed
    Score: 0.245
  16. Improved overall survival and mortality in head and neck cancer with adjuvant concurrent chemoradiotherapy in national databases. Head Neck. 2016 Feb; 38(2):208-15.
    View in: PubMed
    Score: 0.235
  17. Sexual behavior, HPV knowledge, and association with head and neck cancer among a high-risk group. Oral Oncol. 2015 May; 51(5):452-6.
    View in: PubMed
    Score: 0.231
  18. PET-CT and the detection of the asymptomatic recurrence or second primary lesions in the treated head and neck cancer patient. Laryngoscope. 2013 Sep; 123(9):2161-4.
    View in: PubMed
    Score: 0.206
  19. Surgical margin determination in head and neck oncology: current clinical practice. The results of an International American Head and Neck Society Member Survey. Head Neck. 2005 Nov; 27(11):952-8.
    View in: PubMed
    Score: 0.121
  20. Success of multiple, sequential, free tissue transfers to the head and neck. Laryngoscope. 2005 Jan; 115(1):101-4.
    View in: PubMed
    Score: 0.114
  21. Impact of surgical margins on local control in patients undergoing single-modality transoral robotic surgery for HPV-related oropharyngeal squamous cell carcinoma. Head Neck. 2021 08; 43(8):2434-2444.
    View in: PubMed
    Score: 0.088
  22. Hospitalization rates and 30-day all-cause mortality among head and neck cancer patients and survivors with COVID-19. Oral Oncol. 2021 01; 112:105087.
    View in: PubMed
    Score: 0.086
  23. Role of physician density in predicting stage and survival for head and neck squamous cell carcinoma. Head Neck. 2021 02; 43(2):438-448.
    View in: PubMed
    Score: 0.085
  24. Risk Factors for Laryngectomy for Dysfunctional Larynx After Organ Preservation Protocols: A Case-Control Analysis. Otolaryngol Head Neck Surg. 2021 03; 164(3):608-615.
    View in: PubMed
    Score: 0.085
  25. National Database Research in Head and Neck Reconstructive Surgery: A Call for Increased Transparency and Reproducibility. Otolaryngol Head Neck Surg. 2021 02; 164(2):315-321.
    View in: PubMed
    Score: 0.084
  26. Change in stage of presentation of head and neck cancer in the United States before and after the affordable care act. Cancer Epidemiol. 2020 08; 67:101763.
    View in: PubMed
    Score: 0.084
  27. Sociodemographic correlates of head and neck cancer survival among patients with metastatic disease. Head Neck. 2020 09; 42(9):2505-2515.
    View in: PubMed
    Score: 0.084
  28. Intraoperative Margin Assessment in Head and Neck Cancer: A Case of Misuse and Abuse? Head Neck Pathol. 2020 Jun; 14(2):291-302.
    View in: PubMed
    Score: 0.082
  29. Socioeconomic and Demographic Variation in Insurance Coverage Among Patients With Head and Neck Cancer After the Affordable Care Act. JAMA Otolaryngol Head Neck Surg. 2019 12 01; 145(12):1144-1149.
    View in: PubMed
    Score: 0.080
  30. Rising incidence of late-stage head and neck cancer in the United States. Cancer. 2020 03 01; 126(5):1090-1101.
    View in: PubMed
    Score: 0.080
  31. All-Cause 30-Day Mortality After Surgical Treatment for Head and Neck Squamous Cell Carcinoma in the United States. Am J Clin Oncol. 2019 07; 42(7):596-601.
    View in: PubMed
    Score: 0.078
  32. Insurance status, stage of presentation, and survival among female patients with head and neck cancer. Laryngoscope. 2020 02; 130(2):385-391.
    View in: PubMed
    Score: 0.077
  33. In response to letter to the editor regarding: "Patient-reported versus physiologic swallowing outcomes in patients with head and neck cancer after chemoradiation". Laryngoscope. 2019 05; 129(5):E168.
    View in: PubMed
    Score: 0.076
  34. Racial and socioeconomic disparities associated with 90-day mortality among patients with head and neck cancer in the United States. Oral Oncol. 2019 02; 89:95-101.
    View in: PubMed
    Score: 0.075
  35. Patient-reported versus physiologic swallowing outcomes in patients with head and neck cancer after chemoradiation. Laryngoscope. 2019 09; 129(9):2059-2064.
    View in: PubMed
    Score: 0.075
  36. Suicide risk among cancer survivors: Head and neck versus other cancers. Cancer. 2018 10 15; 124(20):4072-4079.
    View in: PubMed
    Score: 0.074
  37. Prevalence and sociodemographic factors associated with depression among hospitalized patients with head and neck cancer-Results from a national study. Psychooncology. 2018 12; 27(12):2809-2814.
    View in: PubMed
    Score: 0.074
  38. Radiation and Second Primary Thyroid Cancer Following Index Head and Neck Cancer. Laryngoscope. 2019 04; 129(4):1014-1020.
    View in: PubMed
    Score: 0.074
  39. Factors associated with increased risk of suicide among survivors of head and neck cancer: A population-based analysis. Oral Oncol. 2018 06; 81:29-34.
    View in: PubMed
    Score: 0.072
  40. Primary Cancer vs Competing Causes of Death in Survivors of Head and Neck Cancer. JAMA Oncol. 2018 Feb 01; 4(2):257-259.
    View in: PubMed
    Score: 0.071
  41. Single-Cell Transcriptomic Analysis of Primary and Metastatic Tumor Ecosystems in Head and Neck Cancer. Cell. 2017 Dec 14; 171(7):1611-1624.e24.
    View in: PubMed
    Score: 0.070
  42. Insufficient Evidence to Support or Refute the Association between Head and Neck Cancer and Marijuana Use. J Evid Based Dent Pract. 2016 Jun; 16(2):127-9.
    View in: PubMed
    Score: 0.063
  43. Identification of molecular signature of head and neck cancer stem-like cells. Sci Rep. 2015 Jan 15; 5:7819.
    View in: PubMed
    Score: 0.057
  44. Evaluation of apoptogenic adenovirus type 5 oncolytic vectors in a Syrian hamster head and neck cancer model. Cancer Gene Ther. 2014 Jun; 21(6):228-237.
    View in: PubMed
    Score: 0.055
  45. Bitter melon reduces head and neck squamous cell carcinoma growth by targeting c-Met signaling. PLoS One. 2013; 8(10):e78006.
    View in: PubMed
    Score: 0.053
  46. FDG PET/CT incidental diagnosis of a synchronous bladder cancer as a fourth malignancy in a patient with head and neck cancer. Clin Nucl Med. 2011 Jun; 36(6):496-7.
    View in: PubMed
    Score: 0.045
  47. Down-regulation of multiple cell survival proteins in head and neck cancer cells by an apoptogenic mutant of adenovirus type 5. Virology. 2009 Sep 15; 392(1):62-72.
    View in: PubMed
    Score: 0.039
  48. Recent advances in otolaryngology-head and neck surgery. Mo Med. 2008 May-Jun; 105(3):196-7.
    View in: PubMed
    Score: 0.036
  49. End-to-side venous anastomosis with the internal jugular vein stump: a preliminary report. Head Neck. 2004 Jun; 26(6):537-40.
    View in: PubMed
    Score: 0.027
  50. Evaluation of chemotherapy response in patients with advanced head and neck cancer using [F-18]fluorodeoxyglucose positron emission tomography. Head Neck. 1997 Dec; 19(8):666-74.
    View in: PubMed
    Score: 0.018
  51. Expression of p53 protein in advanced head and neck squamous cell carcinoma before and after chemotherapy. Arch Otolaryngol Head Neck Surg. 1997 Nov; 123(11):1223-5.
    View in: PubMed
    Score: 0.017
  52. Erythropoietin reduces anemia and transfusions after chemotherapy with paclitaxel and carboplatin. Cancer. 1997 Apr 15; 79(8):1623-8.
    View in: PubMed
    Score: 0.017
  53. Changes in quality-of-life scores in a population of patients treated for squamous cell carcinoma of the head and neck. Head Neck. 1996 Nov-Dec; 18(6):487-93.
    View in: PubMed
    Score: 0.016
  54. Assessment of functional morbidity in the radial forearm free flap donor site. Arch Otolaryngol Head Neck Surg. 1996 Sep; 122(9):991-4.
    View in: PubMed
    Score: 0.016
  55. Relationship between psychological status and compliance in a sample of patients treated for cancer of the head and neck. Head Neck. 1996 May-Jun; 18(3):269-76.
    View in: PubMed
    Score: 0.016
  56. Hair-bearing temporoparietal fascial flap reconstruction of upper lip and scalp defects. Arch Facial Plast Surg. 2001 Jul-Sep; 3(3):170-7.
    View in: PubMed
    Score: 0.006
  57. The temporoparietal fascial flap in head and neck reconstruction. Arch Otolaryngol Head Neck Surg. 1993 Jun; 119(6):618-23.
    View in: PubMed
    Score: 0.003
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.